These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37340430)

  • 1. Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system.
    Mahmoudi Azar L; Karaman E; Beyaz B; Göktan I; Eyüpoğlu AE; Kizilel S; Erman B; Gül A; Uysal S
    BMC Biotechnol; 2023 Jun; 23(1):15. PubMed ID: 37340430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit interleukin-1 receptor antagonist. Cloning, expression, functional characterization, and regulation during intestinal inflammation.
    Cominelli F; Bortolami M; Pizarro TT; Monsacchi L; Ferretti M; Brewer MT; Eisenberg SP; Ng RK
    J Biol Chem; 1994 Mar; 269(9):6962-71. PubMed ID: 7509813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
    Powers NE; Swartzwelter B; Marchetti C; de Graaf DM; Lerchner A; Schlapschy M; Datar R; Binder U; Edwards CK; Skerra A; Dinarello CA
    J Biol Chem; 2020 Jan; 295(3):868-882. PubMed ID: 31819009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.
    Granowitz EV; Clark BD; Mancilla J; Dinarello CA
    J Biol Chem; 1991 Aug; 266(22):14147-50. PubMed ID: 1830582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
    Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
    Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant expression, purification, and characterization of an acyl-CoA binding protein from Aspergillus oryzae.
    Hao Q; Liu X; Zhao G; Jiang L; Li M; Zeng B
    Biotechnol Lett; 2016 Mar; 38(3):519-25. PubMed ID: 26677124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Production and One-Step Purification of IL-1Ra in Escherichia coli and Evaluation of its IL-1 Antagonizing Efficacy.
    Adelnia R; Shafiee F
    Iran J Immunol; 2021 Jun; 18(2):141-149. PubMed ID: 34190695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues.
    Steinkasserer A; Solari R; Mott HR; Aplin RT; Robinson CC; Willis AC; Sim RB
    FEBS Lett; 1992 Sep; 310(1):63-5. PubMed ID: 1388125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning, expression and identification of IL-1ra-Fcepsilon fusion gene].
    Liu Z; Zou M; Wang Y; Wang J; Xu D
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1754-60. PubMed ID: 19149188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris.
    Hamilton BS; Brede Y; Tolbert TJ
    Protein Expr Purif; 2008 May; 59(1):64-8. PubMed ID: 18272394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
    Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
    Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction, expression and preliminary pharmacokinetic analysis of IL-1ra mutants].
    Wang YX; Yang ZX; Zhu HQ; Zhou XW; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):472-6. PubMed ID: 16755929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra.
    Bashir H; Ahmed N; Khan MA; Zafar AU; Tahir S; Kanwal H; Khan F; Rahman ZU; Husnain T
    Biotechnol Appl Biochem; 2017 Jan; 64(1):20-26. PubMed ID: 26620912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
    Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
    Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
    Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity.
    Greenfeder SA; Varnell T; Powers G; Lombard-Gillooly K; Shuster D; McIntyre KW; Ryan DE; Levin W; Madison V; Ju G
    J Biol Chem; 1995 Sep; 270(38):22460-6. PubMed ID: 7673234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
    Tan H; Dan G; Gong H; Cao L
    Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.